Trials in California.
225 APOE4-relevant Alzheimer’s trials run in California — 100 of them recruiting. Each one translated into plain English, with our read on what it means for an APOE4 carrier.
- Where
- Los Angeles · San Francisco · San Diego · Irvine · Palo Alto · Long Beach · La Jolla · Sacramento
- Recruiting
- 100 of 225
Non-carriers only, not for APOE4
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This trial tested bapineuzumab, an infused antibody designed to bind and clear beta amyloid from the brain, against a placebo. It measured whether it helped…
CompletedPhase 3NCT00574132Drug trial for diagnosed APOE4 carriers
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This trial tested whether bapineuzumab, an antibody given by infusion that helps clear beta amyloid from the brain, could affect thinking and daily function in…
CompletedPhase 3NCT00575055Carriers enrolled, but higher ARIA risk
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseThis Phase 2 trial tested lecanemab, an anti-amyloid antibody given by infusion, in people with early Alzheimer's disease — either mild cognitive impairment or…
CompletedPhase 2NCT01767311Built exclusively for APOE 4/4 carriers
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThis trial tested two investigational drugs, CAD106 (a vaccine-like immunotherapy targeting amyloid) and CNP520 (a small molecule targeting amyloid…
TerminatedPhase 2NCT02565511Built specifically for APOE4 carriers
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThis trial tested CNP520, a drug designed to reduce amyloid buildup in the brain, against a placebo in cognitively normal older adults at elevated risk for…
TerminatedPhase 2NCT03131453Open to carriers, but ARIA risk elevated
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseThis Phase 3 trial tests lecanemab, an intravenous and subcutaneous antibody drug, against placebo in people with early Alzheimer's disease — either mild…
ActivePhase 3NCT03887455APOE4 carriers explicitly welcomed
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidThis Phase 3 trial is testing lecanemab, an anti-amyloid antibody drug, in people who are cognitively normal but have early amyloid buildup in their brains —…
ActivePhase 3NCT04468659Built exclusively for APOE4/4 carriers
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD SubjectsThis Phase 3 trial is testing ALZ-801, an oral drug designed to reduce toxic amyloid clusters in the brain, against a placebo in people with early Alzheimer's…
CompletedPhase 3NCT04770220APOE4/4 only, closed to new enrollees
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD SubjectsThis is a long-term extension of a Phase 3 trial testing ALZ-801, an oral drug designed to reduce toxic amyloid clumps in the brain. Researchers are tracking…
TerminatedPhase 3NCT06304883Drug trial for symptomatic early Alzheimer's
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)This trial tests sabirnetug, an antibody given by IV infusion every four weeks, against placebo. It looks at whether the drug slows decline in thinking and…
ActivePhase 2NCT06335173Directly recruits APOE4 carriers
Vascular Intervention Strategies Trial for Alzheimer'sThis small pilot study tests whether a pharmacist-led program can manage high blood pressure and high cholesterol in 10 people. Everyone takes an angiotensin…
Not yet recruitingPhase 2NCT07447206Exclusively recruits APOE4 carriers
Predicting Pre-dementiaThis observational study is testing whether a multimodal prediction model — combining genetic risk scores, blood biomarkers, health record data, and wearable…
RecruitingNCT07516119Exclusively recruits APOE4 carriers
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 CarriersThis trial is testing whether a year-long digital lifestyle coaching program can improve blood-based markers linked to Alzheimer's risk. Twelve hundred…
Invitation onlyObservationalNCT076460544/4 carriers excluded, one copy may qualify
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseaseThis Phase 2 trial is testing SAR448851, a once-daily oral pill, in people with early Alzheimer's disease who have confirmed amyloid buildup in the brain.…
RecruitingPhase 2NCT07688213General AD trial, no APOE4 focus
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseThis Phase 2 trial tested rosiglitazone, a drug originally developed for type 2 diabetes, against a placebo in people with mild to moderate Alzheimer's…
CompletedPhase 2NCT00265148APOE4 enrolled, response may differ
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseThis Phase 3 trial tested rosiglitazone, a diabetes drug, as an add-on to standard Alzheimer's medications like Aricept in people with mild to moderate…
CompletedPhase 3NCT00348140Enrolled carriers, prior data unfavorable
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseThis trial tested whether rosiglitazone extended release, a diabetes drug, could improve thinking and memory in people already taking donepezil for mild to…
CompletedObservationalNCT00348309APOE4 stratified, suggests less benefit
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseThis Phase 3 trial tested rosiglitazone XR, a diabetes drug already approved for type 2 diabetes, as a standalone treatment for mild to moderate Alzheimer's…
CompletedPhase 3NCT00428090Closed trial, APOE4 stratified
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate AlzheimersThis Phase 3 trial tested rosiglitazone XR, a diabetes drug, in people with mild-to-moderate Alzheimer's disease. It was an open-label extension study, meaning…
TerminatedPhase 3NCT00550420Drug trial, genotype not specified in source
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsThis trial tested bapineuzumab, an antibody drug given by infusion, against a placebo in people with mild to moderate Alzheimer's. It looked at how well the…
TerminatedPhase 3NCT00667810Drug trial, not APOE4-specific, carriers at risk
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsThis trial tested bapineuzumab, an antibody drug given by infusion, against a placebo in people with mild to moderate Alzheimer's. Researchers measured safety…
TerminatedPhase 3NCT00676143Open to carriers, not 4-specific
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseThis trial tested SB-742457, an experimental drug added on top of donepezil, the standard Alzheimer's medication, in people with mild-to-moderate Alzheimer's…
CompletedPhase 2NCT00710684Drug extension study, prior participants only
A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsThis trial looked at the long-term safety and tolerability of bapineuzumab, an antibody drug given by infusion, in people with Alzheimer's who had finished an…
TerminatedPhase 3NCT00998764Cancer trial, not for healthy carriers
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesThis trial tests whether a more precise form of whole-brain radiation can spare the hippocampus, the brain's memory center, in people whose cancer has spread…
CompletedPhase 2NCT01227954Not APOE4-related; rare VCP gene study
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)This is a research study, not a drug trial. Investigators are collecting blood, urine, family histories and questionnaires from families with a rare inherited…
RecruitingNCT01353430Huntington's study, not about APOE4
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease CohortEnroll-HD is an observational study, meaning no drug or treatment is given. It follows people with Huntington's disease, and their relatives and controls,…
RecruitingNCT01574053Surgery study, genotype not specified
Effects of Brain Beta-Amyloid on Postoperative CognitionThis study uses a brain scan with a tracer called florbetapir to check for amyloid plaques before hip or knee replacement surgery. Researchers then track…
ActivePhase 4NCT01606488Not for APOE4 carriers; mutation carriers only
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001This trial tests several investigational drugs, including gantenerumab, solanezumab, E2814 and lecanemab, against placebo. It asks whether they slow cognitive…
ActivePhase 2NCT01760005Amyloid-focused, drug did not succeed
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossThis Phase 3 trial tested solanezumab, an antibody drug given by IV infusion, in cognitively normal older adults who already had amyloid buildup in their…
CompletedPhase 3NCT02008357Open to carriers, not 4-specific
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseThis trial tested lanabecestat, a BACE inhibitor drug designed to reduce amyloid production in the brain, against a placebo over two years in people with early…
TerminatedPhase 2NCT02245737Not Alzheimer's-focused, not APOE4-specific
Phenotype, Genotype & Biomarkers in ALS and Related DisordersThis is an observational study, so nothing is being tested as a treatment. Researchers are looking at how the genes and symptoms of ALS and related conditions,…
ActiveNCT02327845Observational depression study, not APOE4-specific
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression ProjectThis observational study follows older adults with late life depression to understand why some develop memory and thinking problems faster. Participants get…
RecruitingNCT02434393Open to carriers, not 4-specific
Exercise in Adults With Mild Memory ProblemsThis trial tests whether aerobic exercise (like treadmill walking) does more for brain health than stretching and balance routines in older adults with mild…
CompletedObservationalNCT02814526Heart trial, genotype not relevant
Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection FractionThis Phase 3 trial tested whether LCZ696 (sacubitril/valsartan, sold as Entresto) protects cognitive function better than valsartan alone in people with a…
CompletedPhase 3NCT02884206Observational only, no treatment involved
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)This study is not testing a treatment. It is an observational study tracking how people with early-stage Alzheimer's disease or MCI use health care, what that…
ActiveNCT02951598Discontinued trial, not APOE4-specific
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaThis Phase 3 trial tested lanabecestat, a BACE inhibitor drug designed to reduce amyloid production in the brain, in people with early Alzheimer's dementia. It…
TerminatedPhase 3NCT02972658Cancer patients only, genotype not specified
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerThis trial is studying whether prostate cancer hormone therapies — specifically abiraterone acetate and enzalutamide — affect brain structure and cognitive…
ActivePhase 4NCT03016741Unrelated to APOE4 or Alzheimer's
The Myelin Disorders Biorepository ProjectThis is a biorepository project, not a treatment trial. Researchers are collecting medical records and biological samples (like blood or tissue) from people…
RecruitingNCT03047369Open to carriers, not 4-specific
Escitalopram for Agitation in Alzheimer's DiseaseThis Phase 3 trial is testing whether escitalopram, a common antidepressant, can safely reduce agitation in people who already have Alzheimer's dementia. Phase…
ActivePhase 3NCT03108846Not relevant: ALS records study, no APOE4
Clinical Procedures to Support Research in ALSThis study uses information already in the medical records of people with ALS and related conditions to learn more about those diseases. It tests no drug or…
RecruitingNCT03489278Open to carriers, not 4-specific
Longitudinal Early-onset Alzheimer's Disease Study ProtocolLEADS is an observational study, not a treatment trial. Researchers are tracking how early-onset Alzheimer's and related conditions progress over time in…
ActiveNCT03507257Designed specifically around APOE4 carriers
DHA Brain Delivery TrialThis trial is testing whether APOE4 carriers absorb less DHA (an omega-3 fatty acid) into the brain compared to non-carriers, and whether DHA supplements can…
CompletedPhase 2NCT03613844Open registry, genotype not required
Alzheimer Prevention Trials (APT) WebstudyThe APT Webstudy is not a treatment trial. It is an online registry that tracks cognitive health over time in people 50 and older who do not have dementia. The…
RecruitingNCT03638583Open to carriers, not 4-specific
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's DiseaseThis trial is testing memantine, an FDA-approved Alzheimer's medication, to understand which patients respond to it best by tracking brain function and symptom…
CompletedPhase 4NCT03703856Open to carriers, genotype not required
Biomarker Exploration in Aging, Cognition and NeurodegenerationThis observational study is tracking brain changes in people 60 and older who currently have normal cognition. Researchers are using MRI, amyloid PET, tau PET,…
RecruitingPhase 3NCT03860857Open to carriers, not 4-specific
Supportive Care for Cognitively Impaired Patients and FamiliesThis trial tests whether a year-long nurse-led palliative care program improves quality of life and reduces healthcare use for people living with dementia or…
ActiveObservationalNCT03881579Not APOE4-related, movement disorder focus
Trial of Parkinson's And Zoledronic AcidThis trial is testing whether a single IV infusion of zoledronic acid, a bone-strengthening drug already approved for osteoporosis, can reduce fractures in…
CompletedPhase 4NCT03924414Open to carriers, genotype not tracked
Metformin in Alzheimer's Dementia PreventionThis trial is testing whether extended-release metformin, a widely used diabetes drug, can slow memory decline in people who are overweight and already showing…
ActivePhase 2NCT04098666Open to carriers, genotype not required
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's DementiaThis trial tests whether treating insomnia with Cognitive Behavioral Therapy for Insomnia (CBT-I) reduces anxiety, depression, agitation, and other behavioral…
ActiveObservationalNCT04100057Huntington's trial, not relevant to APOE4
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's DiseaseThis trial tests AMT-130, a gene therapy delivered by brain surgery into a deep brain region called the striatum, in adults with early Huntington's disease. It…
ActivePhase 1NCT04120493
Copy a forum-ready post
Keep exploring
Educational, not medical advice. Trial decisions belong between you and your physician.